Unknown

Dataset Information

0

Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells.

ABSTRACT: CTG repeat expansion in DMPK, the cause of myotonic dystrophy type 1 (DM1), frequently results in hypermethylation and reduced SIX5 expression. The contribution of hypermethylation to disease pathogenesis and the precise mechanism by which SIX5 expression is reduced are unknown. Using 14 different DM1-affected human embryonic stem cell (hESC) lines, we characterized a differentially methylated region (DMR) near the CTGs. This DMR undergoes hypermethylation as a function of expansion size in a way that is specific to undifferentiated cells and is associated with reduced SIX5 expression. Using functional assays, we provide evidence for regulatory activity of the DMR, which is lost by hypermethylation and may contribute to DM1 pathogenesis by causing SIX5 haplo-insufficiency. This study highlights the power of hESCs in disease modeling and describes a DMR that functions both as an exon coding sequence and as a regulatory element whose activity is epigenetically hampered by a heritable mutation.

SUBMITTER: Yanovsky-Dagan S 

PROVIDER: S-EPMC4618658 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells.

Yanovsky-Dagan Shira S   Avitzour Michal M   Altarescu Gheona G   Renbaum Paul P   Eldar-Geva Talia T   Schonberger Oshrat O   Mitrani-Rosenbaum Stella S   Levy-Lahad Ephrat E   Birnbaum Ramon Y RY   Gepstein Lior L   Epsztejn-Litman Silvina S   Eiges Rachel R  

Stem cell reports 20150716 2

CTG repeat expansion in DMPK, the cause of myotonic dystrophy type 1 (DM1), frequently results in hypermethylation and reduced SIX5 expression. The contribution of hypermethylation to disease pathogenesis and the precise mechanism by which SIX5 expression is reduced are unknown. Using 14 different DM1-affected human embryonic stem cell (hESC) lines, we characterized a differentially methylated region (DMR) near the CTGs. This DMR undergoes hypermethylation as a function of expansion size in a wa  ...[more]

Similar Datasets

Unknown Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.
| S-EPMC3580270 | biostudies-literature
Unknown Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1.
| S-EPMC7428360 | biostudies-literature
Unknown Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
| S-EPMC8831269 | biostudies-literature
Unknown Muscular myopathies other than myotonic dystrophy also associated with (CTG)n expansion at the DMPK locus.
| S-EPMC3611902 | biostudies-literature
Unknown Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.
| S-EPMC7695006 | biostudies-literature
Transcriptomics Effect of the CTG repeat expansion on RNA splicing in children with congenital myotonic dystrophy
2023-02-03 | GSE126342 | GEO
Unknown Replacement of the myotonic dystrophy type 1 CTG repeat with 'non-CTG repeat' insertions in specific tissues.
| S-EPMC3379714 | biostudies-literature
Unknown DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients.
| S-EPMC9349176 | biostudies-literature
Unknown Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
| S-EPMC5304155 | biostudies-literature
Unknown Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy.
| S-EPMC7379817 | biostudies-literature